EUVIMEDExplore EUVIMED
Kohortenstudie

Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study

Heidi E Johnston iD, Melita Andelkovic iD, Hannah L Mayr iD, Yanyan Chen iD, Aaron P Thrift iD, Graeme A Macdonald iD, Ingrid J Hickman iD

Clinical Transplantation · 2024

DOI: 10.1111/ctr.70034 ↗

At a glance

Kohortenstudie in Clinical Transplantation, 2024. Written by Heidi E Johnston and 6 co-authors. Institution: Department of Nutrition & Dietetics, Princess Alexandra Hospital, Brisbane, QLD, Australia. Major MEDLINE topics: Liver Transplantation, Frailty, Postoperative Complications. Cited 4 times so far (Crossref); 52 references. Funded by: University of Queensland.

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

Introduction

Myosteatosis is fat infiltration within skeletal muscle. The impact of myosteatosis on physical function and clinical outcomes in patients referred for liver transplantation (LT) is unclear. We explored associations between myosteatosis and sarcopenia, frailty, physical function, and pre‐ and early post‐LT outcomes.

Methods

Myosteatosis was assessed by computed tomography (CT) in 237 patients referred for LT (March 2018 to September 2022). Chi‐square/Fishers exact tests and multivariable regression compared myosteatosis and sarcopenia, frailty (liver frailty index), physical function (short physical performance battery, SPPB); and associations with pre‐LT unplanned hospitalizations, post‐LT surgical complications (Clavien–Dindo grade ≥ 3), and LT admission length of stay (LOS). Kaplan–Meier and Cox‐proportional hazards models explored myosteatosis and time to LT and unplanned admission. Fine–Gray model evaluated the competing risks of receiving an LT.

Results

Myosteatosis was present in 74 (31%) patients. Patients with myosteatosis were 2.5 times (95% confidence interval [CI] 1.1–5.7, p = 0.03) more likely to be frail, and 3.0 times (95% CI 1.6–5.6, p < 0.001) more likely to have a poor physical function (SPPB ≤ 9/12) than those without myosteatosis. Patients with myosteatosis versus those without were more likely to have a pre‐LT unplanned hospitalization (51% vs. 36%, p = 0.03), but significance was lost after adjusting for age, sex, Model for End‐stage Liver Disease (MELD), and the presence of hepatocellular carcinoma. Myosteatosis did not impact the likelihood of receiving an LT ( p = 0.39), post‐LT complications ( p = 0.93), or LOS in intensive care unit (ICU) ( p = 0.66) or hospital ( p = 0.34).

Conclusions

Myosteatosis is prevalent in patients referred for LT and is associated with impaired physical function. Using existing CTs to assess myosteatosis in practice may help identify physically compromised patients.

Subjects

MeSH terms (MEDLINE)

Liver TransplantationFrailtyPostoperative ComplicationsHumansMaleFemaleMiddle AgedPrognosisFollow-Up StudiesRisk FactorsSarcopeniaMuscle, SkeletalMuscular DiseasesRetrospective StudiesAgedEnd Stage Liver Disease

Author keywords

cirrhosiscomputed tomographyfrailtyliver transplantationmusclemyosteatosis

Authors and institutions

  • Department of Nutrition & Dietetics, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Queensland Liver Transplant Service, Facility is Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
  • Department of Gastroenterology & Hepatology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
  • Centre for Functioning and Health Research, Metro South Health, Brisbane, QLD, Australia.
  • Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

ORCID profiles: Heidi E Johnston, Melita Andelkovic, Hannah L Mayr, Yanyan Chen, Aaron P Thrift, Graeme A Macdonald, Ingrid J Hickman

Funding

  • University of Queensland

Cite

APA

Johnston, H. E., Andelkovic, M., Mayr, H. L., Chen, Y., Thrift, A. P., Macdonald, G. A., & Hickman, I. J. (2024). Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study. Clinical Transplantation. https://doi.org/10.1111/ctr.70034

Vancouver

Johnston HE, Andelkovic M, Mayr HL, Chen Y, Thrift AP, Macdonald GA, et al. Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study. Clinical Transplantation. 2024. doi:10.1111/ctr.70034

BibTeX
@article{Johnston2024,
  author = {Johnston, Heidi E and Andelkovic, Melita and Mayr, Hannah L and Chen, Yanyan and Thrift, Aaron P and Macdonald, Graeme A and Hickman, Ingrid J},
  title = {Myosteatosis Is Associated With Frailty and Poor Physical Function in Patients Undergoing Liver Transplant Evaluation: A Cohort Study},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.70034}
}
Start for free →